What are the recommended antibiotics for bacterial upper respiratory infections (URI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Antibiotics for Bacterial Upper Respiratory Infections

Amoxicillin is the first-line antibiotic treatment for confirmed bacterial upper respiratory infections, with a recommended dosage of 500mg three times daily or 875mg twice daily for adults. 1

Determining Bacterial vs. Viral Etiology

Before initiating antibiotics, it's crucial to determine if the URI is bacterial or viral:

  • Most URIs are viral in origin and do not require antibiotics 2
  • Bacterial infection is more likely when:
    • Symptoms persist for more than 10 days without improvement
    • Symptoms are severe (fever >39°C, purulent nasal discharge, facial pain for >3 consecutive days)
    • Symptoms worsen after initial improvement ("double sickening") 3
    • Fever persists for more than 3 days 3

First-Line Antibiotic Therapy

For confirmed bacterial URIs:

  • Amoxicillin: 500mg three times daily or 875mg twice daily (1.5-4g/day total) 1, 4
    • Duration: 5-7 days for adults, 10-14 days for children 1
    • Target pathogens: Streptococcus species, Streptococcus pneumoniae, Haemophilus influenzae (β-lactamase negative) 4

Alternative First-Line Options (Penicillin Allergy)

For patients with penicillin allergy:

  • Doxycycline: 100mg twice daily 5
  • Macrolides: (e.g., azithromycin) though these have higher failure rates (20-25%) 1

Second-Line Antibiotic Therapy

For treatment failures, high-risk patients, or areas with high resistance rates:

  • Amoxicillin-clavulanate: The reference second-line antibiotic 3, 1
  • Second/third-generation cephalosporins:
    • Cefuroxime-axetil
    • Cefpodoxime-proxetil 3, 1
  • Respiratory fluoroquinolones (reserved for treatment failures or high-risk situations):
    • Levofloxacin
    • Moxifloxacin 1

Specific Considerations by URI Type

Acute Rhinosinusitis

  • Watchful waiting is recommended for uncomplicated cases 3
  • If antibiotics needed, amoxicillin is first-line, with amoxicillin-clavulanate for treatment failures 3, 1
  • Adjunctive therapy: intranasal saline irrigation, intranasal corticosteroids 3

Acute Otitis Media

  • Amoxicillin-clavulanate is preferred 3

Exacerbation of Chronic Bronchitis

  • Simple chronic bronchitis: Antibiotics only if fever persists >3 days 3
  • Chronic obstructive bronchitis: Antibiotics if at least 2 of 3 Anthonisen criteria present (increased dyspnea, increased sputum purulence, increased sputum volume) 3, 1
  • Chronic respiratory insufficiency: Immediate antibiotic therapy recommended 3

Monitoring and Follow-up

  • Assess clinical response after 48-72 hours 1
  • If symptoms worsen or fail to improve:
    • Consider alternative diagnosis
    • Switch to amoxicillin-clavulanate
    • Add coverage for atypical pathogens
    • Consider referral and imaging studies 1

Common Pitfalls to Avoid

  • Prescribing antibiotics for viral URIs (most URIs are viral) 2, 6
  • Using broad-spectrum antibiotics as first-line treatment 7
  • Inadequate duration of therapy (complete the full course even if symptoms improve quickly) 1
  • Using fluoroquinolones for uncomplicated cases (reserve for treatment failures) 3
  • Using cotrimoxazole (poor activity against pneumococci and poor benefit/risk ratio) 3

Remember that judicious use of antibiotics is essential to prevent the emergence of resistant bacteria. Antibiotics should be prescribed only when there is strong clinical evidence of bacterial infection.

References

Guideline

Acute Bacterial Upper Respiratory Infections Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Coping with upper respiratory infections.

The Physician and sportsmedicine, 2002

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.